menu
    • menu
    [{"orgOrder":0,"company":"Astellas Pharma","sponsor":"Edwin Wu","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"JAPAN","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Sestamibi","moa":"Mitochondrial membrane potential","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Astellas Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Astellas Pharma \/ Edwin Wu","highestDevelopmentStatusID":"1","companyTruncated":"Astellas Pharma \/ Edwin Wu"}]

    Find Clinical Drug Pipeline Developments & Deals for Sestamibi

    Menu

    Sestamibi

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Astellas Pharma

                            Japan arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Astellas Pharma

                            Japan arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sestamibi

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Edwin Wu

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Half-Dose Radiopharmaceutical in Wide Beam Reconstruction

                            Details : Cardiolite (99m-Tc Sestamibi) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Myocardial Infarction.

                            Product Name : Cardiolite

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 26, 2011

                            Lead Product(s) : Sestamibi

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Edwin Wu

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth